Drug profile · INN
naltrexone hydrochloride
NALTREXONE HYDROCHLORIDE
naltrexone hydrochloride (NALTREXONE HYDROCHLORIDE) is a opioid receptors; mu/kappa/delta antagonist. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.
Drug details — naltrexone hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 3
- Data quality
- 0.89
Quick answer
naltrexone hydrochloride (NALTREXONE HYDROCHLORIDE) is a opioid receptors; mu/kappa/delta antagonist. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Opioid receptors; mu/kappa/delta antagonist
Primary target: Opioid receptors; mu/kappa/delta
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is naltrexone hydrochloride?
naltrexone hydrochloride (NALTREXONE HYDROCHLORIDE) is a opioid receptors; mu/kappa/delta antagonist. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for naltrexone hydrochloride?
NALTREXONE HYDROCHLORIDE is a marketed brand name for naltrexone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of naltrexone hydrochloride?
naltrexone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.